These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 397754)

  • 1. Macrophage activation for tumor cytotoxicity: mechanisms of macrophage activation by lymphokines.
    Meltzer MS; Ruco LP; Leonard EJ
    Adv Exp Med Biol; 1979; 121B():381-98. PubMed ID: 397754
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
    [No Abstract]   [Full Text] [Related]  

  • 3. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Mar; 120(3):1054-62. PubMed ID: 632578
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophages as cytotoxic effector cells.
    Lohmann-Matthes ML; Lang H; Sun D
    Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
    Boraschi D; Meltzer MS
    Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions.
    Meltzer MS; Ruco LP; Boraschi D; Nacy CA
    J Reticuloendothel Soc; 1979 Oct; 26(4):403-15. PubMed ID: 390144
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic aspects of macrophage activation for tumor cytotoxicity.
    Boraschi D
    Adv Exp Med Biol; 1982; 141():119-28. PubMed ID: 7046393
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammalian macrophage activation factor (s).
    Hibbs JB; Weinberg JB; Chapman HA
    Adv Exp Med Biol; 1979; 121B():433-53. PubMed ID: 232620
    [No Abstract]   [Full Text] [Related]  

  • 10. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Nov; 121(5):2035-42. PubMed ID: 712076
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.
    Meltzer MS
    J Immunol; 1981 Jul; 127(1):179-83. PubMed ID: 7240741
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophage activation for tumor cytotoxicity: tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli.
    Ruco LP; Meltzer MS
    Cell Immunol; 1978 Nov; 41(1):35-51. PubMed ID: 363288
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid killing of actinomycin D-treated tumour cells by mononuclear phagocytes: reactivity in mouse strains with defective classical tumour cytotoxicity.
    Collota F; Bersani L; Polentarutti N; Mantovani A
    Immunology; 1986 Feb; 57(2):249-53. PubMed ID: 3512426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
    Poste G
    Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies on the tumour cytotoxicity of normal, stimulated and immunologically activated mouse macrophages.
    Hansen JG; Bennedsen J; Rhodes JM; Larsen SO
    Acta Pathol Microbiol Immunol Scand C; 1982 Feb; 90(1):27-32. PubMed ID: 7080837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.